Key Takeaways
- The best dental practice broker in the US is typically a national, dental-specific sell-side firm that handles both private-buyer and DSO transactions in meaningful volume.
- The criteria that matter most are dental-only focus, sell-side exclusivity, a CPA-led diligence-grade EBITDA valuation, and a structured competitive bid process. McLerran & Associates is the firm in this guide that meets all four.
- Sellers can use six key questions on the first call to evaluate a broker: transaction volume, valuation accuracy, buyer relationships, sell-side exclusivity, fee transparency, and competitive process.
- Free valuations often function as marketing tools and can increase the risk of price cuts during diligence, while a CPA-led valuation tends to hold up better when buyers scrutinize the numbers.
- McLerran & Associates helps owners of premier practices maximize value and find the right fit through its both-paths model and national coverage.
Schedule a Discovery Call with McLerran & Associates
How To Evaluate A Dental Practice Broker Before You Sign
The six questions below give a practical way to separate a true sell-side advisor from a basic listing agent. Ask all six on the first call and request the answers in writing.
- How many dental transactions have you closed in the last 24 months? Ask for a specific count of dental-only deals, not a blended total across several industries. An advisor who cannot point to multiple closed dental deals in the last 24 months is effectively learning on your transaction. McLerran & Associates has completed roughly 2,000 successful practice sales and evaluates approximately 500 practices per year.
- How does your final sale price compare with your initial valuation? Look for a firm that tracks initial valuation against final price and can describe the typical gap. A pattern of downward price changes in diligence signals that the original valuation did not meet diligence-grade standards.
- Which DSO and private-equity buyers do you have active relationships with? Seek current, specific buyer activity. A vague reference to “national consolidators” suggests the advisor is not actively working that market. ProCloser’s 2026 dental M&A advisor guide recommends asking for the current acquisition criteria of three buyers the advisor has dealt with in the last six months. A detailed answer indicates real market presence.
- Do you represent sellers exclusively, or both sides? Prefer a sell-side-only model with no buyer fees. McLerran & Associates represents only sellers, and its compensation depends entirely on the seller’s outcome. Some national firms practice dual representation, meaning they represent both buyer and seller in the same transaction, which creates a conflict-of-interest trade-off that sellers must weigh carefully.
- What are your fees, retainer, and termination terms? Ask for a written fee schedule, clear language on any marketing retainers, and a specific tail clause. Dental broker commissions commonly range from 8% to 12% of the sale price, with minimum fees that can raise the effective rate on smaller transactions. Tail clauses can require a fee for six to 24 months after a listing terminates if a buyer introduced during the engagement later closes, so the fine print deserves careful review.
- Do you run a competitive bidding process or take the first offer? Favor a structured process among vetted buyers. McLerran’s DSO bid process typically runs approximately 45 to 60 days and generates around 10 offers per listing. A competitive process with multiple funded buyers tends to produce materially better outcomes than a direct, uncontested offer. On a practice of meaningful size, a single additional EBITDA multiple point (EBITDA is earnings before interest, taxes, depreciation, and amortization, the profit figure institutional buyers use to value a practice) can exceed the entire cost of representation.
Every answer should come with data behind it. A firm confident in its track record will show the numbers rather than describe them.
Doctor-To-Doctor Vs. DSO: Which Broker Handles Both Paths Well?
Dental practice owners usually face two main transition pathways. The first is a doctor-to-doctor sale, in which the practice is sold to another individual dentist, typically financed through an SBA loan. The second is a DSO affiliation, in which the practice affiliates with a dental service organization or private-equity-backed group, often in exchange for a mix of cash at closing, rollover equity (a portion of proceeds reinvested into the acquiring platform), and an earnout (additional payments tied to future performance targets).
A broker who runs only one of these lanes limits the seller’s outcome, because the owner never sees what the other market would pay for the same practice. The same practice can carry materially different valuations depending on buyer type, and the gap between an individual-dentist offer and an institutional offer can be significant. Owners in the middle of the market, roughly $1.5M to $3M in annual revenue, can often go either way, and choosing a path without seeing both numbers can mean leaving a large sum on the table.
McLerran & Associates is one of the few national firms working both paths in roughly equal measure, which allows owners to receive a true side-by-side valuation before committing to either direction. As a general orientation, practices in the roughly $1M to $1.5M revenue range often fit a doctor-to-doctor sale. Practices above $3M in revenue tend to point toward the DSO path. Practices in the $1.5M to $3M range can go either way, depending on the practice’s financials, structure, and the owner’s goals.
Dental Practice Transition Options: Private Sale Vs. DSO covers the mechanics of each path in detail. The both-paths test, which asks whether a broker handles both paths at diligence-grade quality, can be one of the most useful filters when building a shortlist of advisors.
How The Main Categories Of Dental Practice Brokers Compare
The following comparison outlines the main categories of dental practice brokers and transition firms available to sellers in the US. The focus is how well each category serves owners of premier practices who want to see both a private-buyer and a DSO number before committing.
McLerran & Associates is dental-only and sell-side-only, runs private-buyer and DSO transactions in roughly equal measure, and backs every engagement with a CPA-led, diligence-grade EBITDA valuation and a structured competitive bid process. The firm has completed roughly 2,000 successful practice sales, closed approximately $2 billion in transaction volume, and evaluated more than 10,000 practices. Its transaction rate of approximately 85% to 90% compares to an industry norm closer to 35% to 40%. National offices in Cleveland, Atlanta, Northern Virginia, Los Angeles, and Phoenix provide broad coverage.

National dental transition firms that lean single-lane bring deep experience and national reach, yet are typically weighted toward one transition path, most commonly the doctor-to-doctor side. The owner sees one market’s number rather than two, which can mean committing to a path without knowing what the other market would have paid. Valuations from these firms are often a self-reported opinion of value rather than a diligence-grade analysis, which creates re-trade risk when a buyer’s accountants look under the hood. That combination, one lane and one opinion, is why McLerran’s both-paths model and CPA-led valuation represent a meaningfully different offering for owners of premier practices.
Multi-vertical sell-side advisors bring real M&A experience, yet dental is one line among several specialties they serve. Buyer relationships and specialty nuance tend to be thinner than those of a dental-only firm, and the team is not exclusively focused on the dynamics of dental consolidation.
Local generalist brokers know the community and can be effective for straightforward transactions. They typically have limited buyer exposure, lighter work product, and infrequent deal flow. Because they transact less frequently, institutional buyers tend to bid less aggressively on their listings over time.
Free-valuation lead-generation firms offer a valuation as a marketing tool. A broker’s opinion of value is often free because the broker expects to obtain the listing afterward, creating an incentive to appraise high. A number set high to win the listing becomes the anchor that determines what the owner walks away with, and a weak valuation often gets re-traded when the buyer’s diligence team tests it.
Do-it-yourself / for-sale-by-owner carries no broker fee and also no built-in competitive tension. Do-it-yourself close rates run as low as 15% to 20%, versus roughly 80% for a well-run brokered process, and the valuation is effectively set by the buyer.
What Dental Practice Brokers Charge And How Valuation Quality Affects Net Proceeds
Whichever category a seller chooses, the fee structure usually follows the same pattern, and it is closely tied to how valuation quality affects the final outcome. Dental practice broker commissions are typically structured as a success fee, a percentage of the final sale price paid at closing. Common commission ranges run from 8% to 12% for single-location practices, with minimum fees that can raise the effective rate on smaller transactions. Some engagements also include monthly marketing retainers charged whether or not the practice sells, and tail clauses that can extend a broker’s fee claim for six to 24 months after the listing terminates. Because a tail clause can outlast the engagement itself, the fee schedule is worth reading line by line before signing. Ask what is owed if the engagement ends early and which buyers the tail clause actually covers.
The “free valuation” model deserves particular scrutiny. A back-of-the-napkin number set to win a listing becomes the anchor for everything that follows. A re-trade, which is a price revision after diligence identifies risks not adequately supported in the initial valuation, is the weakest position in the whole transaction, because by that point the seller has typically gone exclusive with one buyer and has no competitive alternative. Add-backs are adjustments that increase reported earnings, such as removing personal expenses or above-market owner compensation. Undocumented add-backs get disallowed, and each disallowed dollar is multiplied by the valuation multiple. A $130,000 adjustment error at an 8x multiple moves the price by more than $1 million.
McLerran & Associates builds a CPA-led, diligence-grade EBITDA analysis up front, before the practice goes to market. Every add-back is unpacked and documented so the number has a stronger chance of holding when buyers scrutinize it. In one case, a free valuation placed a practice at $2.5 million. McLerran valued it at $4.5 million, and it sold for $5.25 million after a competitive process. The firm states its positioning directly: “we don’t just list practices, we sell practices.” This content is educational in nature, and sellers should consult their own tax and legal advisors on the structure and implications of any transaction.

Best Dental Practice Broker: How to Choose an Advisor provides additional guidance on evaluating advisor fit before signing an engagement.
When To Start The Conversation
Choosing the right advisor and the right valuation method only helps if there is enough time to act on either. Most practice owners contact a transitions professional or broker far too late, on average about one year before they want to exit, whereas advisors often recommend engaging a broker roughly 3 to 5 years before a planned sale. Starting early allows time to address the factors that can be some of the main drivers of valuation, such as provider concentration, associate agreements, equipment condition, and financial documentation, before a buyer’s diligence team reviews them. The actions most reliably improving dental practice valuation are typically taken 12 to 24 months before a sale, rather than in the weeks after a letter of intent (LOI) is signed.
Demand for premier, Class A practices remains steep, and valuations for well-run practices sit near all-time highs. DSO-related transactions represented the clear majority of reported quarterly dental deals in Q3 2026, and the global DSO market is projected to grow at approximately 17.4% annually through 2032, which creates a structural tailwind for sellers of well-positioned practices.
If an owner is not ready to sell today, McLerran & Associates will update a valuation for free a year later rather than push a deal before the timing is right. The firm’s national footprint, including Cleveland (Justin Klingshim), Atlanta (Matt Sutton), Northern Virginia (Andrew Kobylski), Los Angeles (Steven Au), and Phoenix (Brian Carroll, covering the Mountain West), means a local conversation is available for most practice locations.
Owners who want to get educated before committing to any path can also attend the McLerran M&A Summit (October 29–30, 2026, Austin), a dental-only event built for owners who have not yet decided to sell. Attendees receive 4 CE credits and a complimentary practice valuation (a $2,500 value).

Conclusion: The Framework, The Test, And Your Next Step
The six-question framework, covering transaction volume, valuation accuracy, buyer relationships, sell-side exclusivity, fee transparency, and competitive process, gives any seller a structured way to separate a real sell-side advisor from a listing agent on the first call. The both-paths test, which asks whether a firm runs private-buyer and DSO transactions at diligence-grade quality, can be one of the most useful filters for ranking every category of advisor, because a firm that works only one lane cannot show an owner what the other market would pay.
McLerran & Associates is the best dental practice broker in the US for owners of premier practices who want to maximize value and see both markets before committing. The four criteria above are the reason, and the both-paths split described earlier is what makes the side-by-side comparison possible.
With the framework and the test in hand, the next step is to apply them. Clarify your goals, review your financials, and then put the six questions to a dental-specific sell-side advisor who works exclusively for sellers.
Put These Six Questions To McLerran & Associates
Frequently Asked Questions
What Is The Best Dental Practice Broker In The US?
The best dental practice broker for a given owner is the one best matched to that practice’s size, transition path, and goals. For owners of premier practices, typically $1 million or more in annual revenue, who want to maximize value and see both transition paths before committing, the defining criteria are dental-only focus, sell-side exclusivity, a CPA-led diligence-grade valuation, and a structured competitive bid process among a vetted buyer pool. McLerran & Associates meets all four criteria, and its both-paths model supports the side-by-side comparison described earlier.
Should I Sell To A Private Buyer Or A DSO?
The right path depends on your practice’s size, profitability, and your personal goals. Practices in roughly the $1M to $1.5M revenue range often fit a doctor-to-doctor sale. Practices above $3M in revenue tend to point toward the DSO path. Owners in the $1.5M to $3M range can often go either way. Because the same practice can carry materially different valuations in the two markets, the most informed decision usually comes from seeing a side-by-side comparison of both paths before choosing, which requires an advisor who works both lanes.
Why Should I Pay For A Valuation When Other Firms Do It For Free?
A free valuation is typically a lead-generation tool, a number set to win the listing rather than to hold up in diligence. When a buyer’s accountants test the add-backs and find them unsupported, the price often gets re-traded downward by a multiple of the disallowed amount. A CPA-led, diligence-grade analysis done before the practice goes to market means the number is more defensible when buyers scrutinize it, and the agreed value has a better chance of holding through closing. A weak valuation costs far more than the fee it saves, because every dollar stripped out in diligence is multiplied by the valuation multiple.
How Do I Know Which DSOs Are The Good Ones?
Vetting buyers is a core part of a sell-side advisor’s job. The DSO market includes well-backed, well-run organizations and weaker ones, including some that emerged when capital flooded the space and have since struggled. A good advisor maintains an active buyer pool, has blacklisted organizations known for poor post-close environments, and helps owners review a DSO’s financial health, management team, and track record before any offer is accepted. Partnering with an undercapitalized DSO can put a significant portion of rollover equity, which can represent up to roughly 40% of a deal’s total value, at risk if the platform later struggles.
Are DSO Deals All Cash, Or Is There Stock Involved?
DSO deals are almost always a mix of cash at closing, rollover equity, and an earnout. Rollover equity can be held at the joint-venture level, with ongoing distributions but a lower ceiling, or at the holding-company level, with no distributions but a higher potential ceiling if the platform is recapitalized or sold. The equity portion is illiquid until a future sale or recapitalization event, so its ultimate value depends on the platform’s performance. Multi-year financial modeling that compares real after-tax proceeds across deal structures and time horizons can be one of the most reliable ways to evaluate what a DSO offer is actually worth.
Do I Have To Keep Working After I Sell?
On a DSO affiliation, a multi-year working agreement, typically a minimum of 5 years, is standard. The length and terms are negotiable, and a good advisor will push for non-punitive earnout provisions and a structure that reflects the owner’s actual clinical role. On a doctor-to-doctor walk-away sale, the seller typically works back only approximately 4 to 8 weeks before exiting. The right structure depends on the owner’s goals and the practice’s dependence on the selling dentist’s production.
Is Now A Good Time To Sell?
Demand for premier, Class A practices remains strong, and valuations for well-run practices sit near all-time highs. DSO acquisition activity is projected to increase, and the structural shift away from private practice ownership continues to grow the pool of institutional buyers. Timing remains practice-specific, so a candid conversation with a dental-specific sell-side advisor is often the most reliable way to understand how your practice is positioned in the current market. If you are not ready to sell today, starting the valuation process now gives you a baseline and time to address any factors that could affect your outcome.